SCHEMBL18856015

SCHEMBL18856015

O=C(ON1C(=O)CCC1=O)c1ccc(C2=C3C=CC(O)C=C3Oc3cc(O)ccc32)c(C(=O)O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14597208 0.82 — —
SCHEMBL14627858 0.80 — —
SCHEMBL22651668 0.80 HSD17B10 (0.31) —
SCHEMBL18934462 0.79 MEN1 (0.31) —
SCHEMBL22193121 0.78 HSD17B10 (0.47) —
SCHEMBL18882644 0.78 — —
SCHEMBL23767368 0.78 — —
SCHEMBL20887111 0.76 MEN1 (0.34) —
SCHEMBL23425343 0.76 MEN1 (0.37) —
SCHEMBL22755523 0.74 ESR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650363-B2 Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1 HOFFMANN-LA ROCHE INC. (US) 2017-05-16 — — US disclosed
Send feedback